Back to first-pass browser

First-pass extracted concept

isopsoralen

Candidate: concept label1 source documents3 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Isopsoralen is presented as a bioactive constituent from Psoralea corylifolia associated with NSCLC suppression through STAT3 inhibition and ROS modulation.

Source 1

What problem it solves

In this paper context, it is positioned as a candidate antitumor small molecule for NSCLC-related phenotypes.

Source 1

What it does not solve

The provided evidence does not establish dosing, selectivity, delivery, or translational safety performance within this paper payload.

Source 1

Alternatives

The same source context contrasts isopsoralen with psoralen as a closely related co-reported compound.

Source 1

Evidence Snippets

The source title and web research summary identify isopsoralen as one of the compounds from Psoralea corylifolia reported to suppress NSCLC by STAT3 inhibition and ROS modulation.
Evidence 1Source 1provenance

Supporting Sources

Linked Claims

Claim 1cellular activitysupports2026Source 1

The anchor paper context reports that psoralen and isopsoralen inhibit A549 NSCLC phenotypes.

Claim 2mechanism and activitysupports2026Source 1

Psoralen and isopsoralen from Psoralea corylifolia suppress NSCLC by dual mechanisms involving STAT3 inhibition and ROS modulation.

Claim 3target engagementsupports2026Source 1

The anchor paper context reports that psoralen and isopsoralen bind STAT3.